Friday, July 31, 2026

From ICBM Launches to Family Rivalry — Trouble Inside Pyongyang?

Kim Jong Un's potential successor, Ju-ae, may face a power struggle with her aunt Kim Yo-jong, who has significant political backing.

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

Kim Yo-jong Rejoins North Korea’s Power Circle: What This Means for 2026

Kim Yo-jong returns to North Korea's Politburo, signaling a shift in foreign policy and leadership dynamics within the Workers' Party.

Tag: Chong Kun Dang

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.